Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria

NCT03157635 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Paroxysmal Hemoglobinuria, Nocturnal

Interventions

DRUG: Crovalimab
DRUG: Placebo

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]